The risk of transmitting HCV, HBV or HIV by blood transfusion in Victoria

Medical Journal of Australia

Volumn 166, Issue 11, 1997, Pages 584-586

  Whyte, Gordon S ^a,b   Savoia, Helen F ^a  

^a Red Cross Blood Bank   (United States)

^b NONE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AUSTRALIA; BLOOD DONOR; BLOOD TRANSFUSION; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFECTION RISK; VIRUS TRANSMISSION;

EID: 0030954337     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.1997.tb123269.x     Document Type: Article

References (12)

1. Dax EM, Healey DS, Crofts N. Low risk of HIV-1 infection from blood donation: a test-based estimate. Med J Aust 1992; 157: 69.
2. Schreiber GB, Busch MR Kleinman SH, Korelitz JJ. The risk of transfusion-transmitted viral infections. N Engl J Med 1996; 334: 1685-1690.
3. Busch MR Korelitz. JJ, Kleinman SH, et al. Declining value of alanine aminotransferase in screening of blood donors to prevent posttransfusion hepatitis B and C virus infections. Transfusion 1995; 35: 903-910.
4. Strasser SI, Smith BC, Watson KJR, et al Evaluation of blood donors with equivocal hepatitis C serological results. Med J Aust 1995; 162: 459-461.
5. Mimms LT, Mosely JW, Hollinger FB, et al. Effects of concurrent acute infection with hepatitis C on hepatitis B virus infection. BMJ 1993; 307: 1095-1097.
6. Lelie PN, Cuypers HT, Reesink HW, et al. Patterns of serological markers in transfusion transmitted hepatitis C infection using second generation HCV assays. J Med Virol 1992; 37: 203-209.
7. Busch MR Lee LL, Satten GA, et al. Time course of detection of viral and serological markers preceding human immunodeficiency virus type 1 seroconversion: implications for screening blood and tissue donors. Transfusion 1995; 35: 91-97.
8. Courouce A-M, Pillonel J. Transfusion transmitted viral infections. N Engl J Med 1996; 335: 1609-1610.
9. Kaldor JM, Plant AJ, Thompson SC, et al. The incidence of hepatitis B infection in Australia: an epidemiological review. Med J Aust 1996; 165: 322-326.
10. Andrews R, Curran M. Enhanced surveillance for incident cases of hepatitis C in Australia, 1995. Communicable Diseases Intelligence 1996; 20: 384-388.
11. Locarnini S, McAnutty. Hepatitis C surveillance [editorial]. Communicable Diseases Intelligence 1996; 20: 388-389.
12. Feachem RGA. Valuing the past - investing in the future: evaluation of the National HIV/AIDS Strategy 1993-94 to 1995-96. Canberra: Commonwealth Department of Human Services and Health, 1995: 29-40.